149 related articles for article (PubMed ID: 22177326)
1. Meta-analysis: serum creatinine changes following contrast enhanced CT imaging.
Kooiman J; Pasha SM; Zondag W; Sijpkens YW; van der Molen AJ; Huisman MV; Dekkers OM
Eur J Radiol; 2012 Oct; 81(10):2554-61. PubMed ID: 22177326
[TBL] [Abstract][Full Text] [Related]
2. Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: a meta-analysis.
Moos SI; van Vemde DN; Stoker J; Bipat S
Eur J Radiol; 2013 Sep; 82(9):e387-99. PubMed ID: 23711425
[TBL] [Abstract][Full Text] [Related]
3. In emergency situations, should serum creatinine be checked in all patients before performing second contrast CT examinations within 24 hours?
Abujudeh HH; Gee MS; Kaewlai R
J Am Coll Radiol; 2009 Apr; 6(4):268-73. PubMed ID: 19327660
[TBL] [Abstract][Full Text] [Related]
4. Contrast-induced nephrotoxicity in renal allograft recipients.
Ahuja TS; Niaz N; Agraharkar M
Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of patient questionnaire in predicting renal dysfunction in outpatients older than 60 years of age prior to contrast-enhanced computed tomography.
Lui EH; Lau KK; Polkinghorne K; Chang CA; Ardley N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):168-72. PubMed ID: 22498189
[TBL] [Abstract][Full Text] [Related]
6. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
Solomon R; Dumouchel W
Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
[TBL] [Abstract][Full Text] [Related]
7. The incidence of contrast-induced nephropathy in trauma patients.
Hipp A; Desai S; Lopez C; Sinert R
Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
Toso A; Maioli M; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Manzone C; Amato M; Bellandi F
Am J Cardiol; 2010 Feb; 105(3):288-92. PubMed ID: 20102936
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials.
Zhang L; Zhang L; Lu Y; Wu B; Zhang S; Jiang H; Ge J; Chen H
Int J Clin Pract; 2011 May; 65(5):624-30. PubMed ID: 21489086
[TBL] [Abstract][Full Text] [Related]
11. Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and outcome.
Lakhal K; Ehrmann S; Chaari A; Laissy JP; Régnier B; Wolff M; Pajot O
J Crit Care; 2011 Dec; 26(6):593-9. PubMed ID: 21737245
[TBL] [Abstract][Full Text] [Related]
12. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
[TBL] [Abstract][Full Text] [Related]
13. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
Worasuwannarak S; Pornratanarangsi S
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
[TBL] [Abstract][Full Text] [Related]
14. Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography.
Hong SI; Ahn S; Lee YS; Kim WY; Lim KS; Lee JH; Lee JL
Support Care Cancer; 2016 Mar; 24(3):1011-7. PubMed ID: 26238629
[TBL] [Abstract][Full Text] [Related]
15. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
Zagler A; Azadpour M; Mercado C; Hennekens CH
Am Heart J; 2006 Jan; 151(1):140-5. PubMed ID: 16368307
[TBL] [Abstract][Full Text] [Related]
16. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
[TBL] [Abstract][Full Text] [Related]
17. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.
Marenzi G; Lauri G; Assanelli E; Campodonico J; De Metrio M; Marana I; Grazi M; Veglia F; Bartorelli AL
J Am Coll Cardiol; 2004 Nov; 44(9):1780-5. PubMed ID: 15519007
[TBL] [Abstract][Full Text] [Related]
18. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
Nyman U; Björk J; Aspelin P; Marenzi G
Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
[TBL] [Abstract][Full Text] [Related]
19. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists.
Reddan D; Fishman EK
Eur J Radiol; 2008 May; 66(2):235-45. PubMed ID: 17728089
[TBL] [Abstract][Full Text] [Related]
20. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
Kandula P; Shah R; Singh N; Markwell SJ; Bhensdadia N; Navaneethan SD
Nephrology (Carlton); 2010 Mar; 15(2):165-70. PubMed ID: 20470274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]